Eugenii A Rabiner Selected Research

Eugenii A Rabiner Research Topics

Disease

14	Schizophrenia (Dementia Praecox) 02/2024 - 05/2004
8	Neuroinflammatory Diseases 12/2020 - 01/2011
8	Parkinson Disease (Parkinson's Disease) 01/2020 - 10/2015
7	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2010
5	Cognitive Dysfunction 02/2024 - 08/2017
4	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020 - 03/2012
4	Inflammation (Inflammations) 01/2020 - 12/2016
3	Psychological Sexual Dysfunctions (Sexual Arousal Disorder) 01/2023 - 01/2020
3	Multiple Sclerosis 11/2017 - 07/2014
2	Mental Disorders (Mental Disorder) 09/2023 - 01/2014
2	Atrophy 01/2022 - 11/2017
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2020 - 12/2016
2	Gambling (Pathological Gambling) 01/2020 - 11/2017
2	Alcoholism (Alcohol Abuse) 01/2020 - 06/2014
2	Disease Progression 10/2019 - 11/2017
2	Opioid-Related Disorders (Opiate Addiction) 11/2017 - 01/2016
2	Huntington Disease (Huntington's Disease) 09/2016 - 10/2015
2	Substance-Related Disorders (Drug Abuse) 01/2016 - 01/2014
2	Psychotic Disorders (Schizoaffective Disorder) 08/2015 - 09/2002
2	Major Depressive Disorder (Major Depressive Disorders) 08/2013 - 03/2012
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 09/2023
1	Neuralgia (Stump Neuralgia) 01/2022
1	Synucleinopathies 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2020
1	Proteostasis Deficiencies 01/2020
1	Gliosis 10/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2019
1	Rheumatoid Arthritis 01/2018
1	Neurobehavioral Manifestations 08/2017
1	Dementia (Dementias) 08/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2016
1	Spinal Cord Diseases 12/2016
1	Encephalitis (Encephalitis, Rasmussen) 12/2016
1	Crohn Disease (Crohn's Disease) 11/2016
1	Dyskinesias (Dyskinesia) 10/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 11/2013
1	Obesity 11/2011

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2013
6	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2020 - 10/2015
5	LigandsIBA 10/2021 - 01/2014
5	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2011
4	Glycoproteins (Glycoprotein)IBA 06/2023 - 01/2020
4	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2023 - 01/2016
3	KisspeptinsIBA 01/2023 - 01/2020
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 10/2021
3	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 02/2005
3	Dopamine D3 ReceptorsIBA 12/2016 - 01/2014
3	Dopamine (Intropin)FDA LinkGeneric 08/2015 - 06/2007
3	5-HT1A Serotonin ReceptorIBA 09/2008 - 05/2004
2	Glutamic Acid (Glutamate)FDA Link 02/2024 - 01/2021
2	Histamine (Histamine Dihydrochloride)FDA Link 10/2023 - 07/2010
2	carfentanil (carfentanyl)IBA 01/2023 - 10/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2010
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2020 - 01/2019
2	RolipramIBA 01/2020 - 08/2017
2	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 09/2002
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020 - 08/2017
2	EnzymesIBA 01/2020 - 10/2015
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2020 - 01/2020
2	SynucleinsIBA 10/2019 - 01/2019
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 10/2019 - 01/2019
2	Levodopa (L Dopa)FDA LinkGeneric 08/2017 - 10/2015
2	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2017 - 12/2016
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 09/2008 - 02/2005
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 10/2023
1	Hallucinogens (Psychedelics)IBA 09/2023
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 11/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Sigma-1 ReceptorIBA 01/2022
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 10/2021
1	N- benzyl- N- ethyl- 2- (7,8- dihydro- 7- methyl- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 10/2021
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2021
1	Purinergic P2X7 ReceptorsIBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	ImidazolinesIBA 10/2019
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2019
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2019
1	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	GABA-A Receptors (GABA(A) Receptor)IBA 11/2017
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2017
1	GSK2647544IBA 01/2017
1	naxagolideIBA 12/2016
1	Dopamine Receptors (Dopamine Receptor)IBA 12/2016
1	FluorineIBA 11/2016
1	Huntingtin ProteinIBA 09/2016
1	Opioid Receptors (Opioid Receptor)IBA 01/2016
1	IMA107IBA 01/2016
1	Cocaine (Cocaine HCl)IBA 01/2016
1	GSK215083IBA 12/2015
1	3- benzenesulfonyl- 8- piperazin- 1- ylquinolineIBA 12/2015
1	(18F)FEMPAIBA 03/2015
1	1- (3,4- dichlorophenyl)- 6- (methoxymethyl)- 4- azabicyclo(4.1.0)heptaneIBA 08/2013
1	HeptanesIBA 08/2013
1	Harmine (Telepathine)IBA 03/2012
1	Monoamine Oxidase (MAO)IBA 03/2012
1	Glycine Plasma Membrane Transport ProteinsIBA 12/2011

Therapy/Procedure

6	Therapeutics 09/2023 - 01/2010
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2014